EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Systematic Review on 1,2,3‐Oxadiazoles, 1,2,4‐Oxadiazoles, and 1,2,5‐Oxadiazoles in the Antimycobacterial Drug Discovery

Marta Kučerová-Chlupáčová iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400971 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ChemMedChem, 2025. Verfasst von Marta Kučerová-Chlupáčová. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského …. Hauptthemen laut MEDLINE: Antitubercular Agents, Drug Discovery, Mycobacterium tuberculosis, Oxadiazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a leading global health threat, exacerbated by the emergence of multi‐drug‐resistant strains. The search for novel therapeutic agents is critical in addressing this challenge. This review systematically summarizes the potential of oxadiazole derivatives as promising candidates in antimycobacterial drug discovery. We focus on various classes of oxadiazoles, especially 1,2,3‐oxadiazoles, 1,2,4‐oxadiazoles, and 1,2,5‐s in structure‐activity relationship studies are discussed, emphasizing the mechanisms of antimycobacterial action. Additionally, the synergistic potential of 1,2,4‐oxadiazoles in enhancing the efficacy of existing tuberculosis treatment with ethionamide is also discussed. By integrating insights from recent research, this review aims to provide a comprehensive overview of the role of oxadiazoles in the fight against tuberculosis, paving the way for future investigations and the development of effective therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsDrug DiscoveryMycobacterium tuberculosisOxadiazolesTuberculosisHumansMicrobial Sensitivity TestsMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

1,2,3-oxadiazole1,2,4-oxadiazole1,2,5-oxadiazoleMycobacterium tuberculosisethionamide-boosting effect

Substanzen

Antitubercular AgentsOxadiazoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203/8, 50003, Hradec Králové, Czech Republic.

ORCID-Profile: Marta Kučerová-Chlupáčová

Zitieren

APA

Kučerová-Chlupáčová, M. (2025). Systematic Review on 1,2,3‐Oxadiazoles, 1,2,4‐Oxadiazoles, and 1,2,5‐Oxadiazoles in the Antimycobacterial Drug Discovery. ChemMedChem. https://doi.org/10.1002/cmdc.202400971

Vancouver

Kučerová-Chlupáčová M. Systematic Review on 1,2,3‐Oxadiazoles, 1,2,4‐Oxadiazoles, and 1,2,5‐Oxadiazoles in the Antimycobacterial Drug Discovery. ChemMedChem. 2025. doi:10.1002/cmdc.202400971

BibTeX
@article{KuerovChlupov2025,
  author = {Kučerová-Chlupáčová, Marta},
  title = {Systematic Review on 1,2,3‐Oxadiazoles, 1,2,4‐Oxadiazoles, and 1,2,5‐Oxadiazoles in the Antimycobacterial Drug Discovery},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400971}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche